Minister for Higher Education and Research Claude Meisch at the inauguration of the Clinnova project focusing on precision medicineArtificial intelligence (AI) has huge potential to enhance healthcare but its implementation faces challenges, notably in the context of data enabling and the ability to build appropriate clinical studies. The objective of the Clinnova project, which is supported by the Luxembourg National Research Fund (FNR), the Grand Est Region in France, the Swiss Canton of Basel and the German State of Baden-Württemberg, is to foster AI-driven precision medicine via data federation, standardization, and interoperability.

Advancing precision medicine

To date, there are no straightforward methods available to decide which drug to prescribe to which patient. With new drugs coming on the market in a steady flow, physicians and patients are faced with a concrete problem: the wrong therapy may aggravate the disease and incur unnecessary cost for the social system. Clinnova was conceived as a precision medicine initiative that tackles these challenges on three levels.

Clinnova primarily focuses on generating benefits for patients and physicians regarding three diseases: inflammatory bowel disease, rheumatoid diseases and multiple sclerosis. With an emphasis on data quality and standardisation, the goal is to develop effective AI algorithms that can support physicians in prescribing the right drug to an individual patient at the right time. Furthermore, these data can accelerate translational research into disease causes, which can further affect patient care.

We envision that in a data-enabled environment, the translation and application of biomedical research towards patients will become a seamless routine process.

Clinnova will also bridge the worlds of biomedical research and healthcare by fostering critical infrastructure development in Luxembourg. It will undertake the necessary steps to assure data interoperability and integration in this infrastructure concept.

Finally, Clinnova will federate precision health data across borders. The Clinnova team in Luxembourg has teamed up with universities and clinical centres in Baden-Württemberg in Germany, the Grand Est region in France, and the region of Basel in Switzerland to invest in similar Clinnova precision health programmes and link the IT infrastructures set up. The Clinnova partners are thus building a federated precision health network across Europe.

Artificial intelligence solutions for healthcare

Overall, AI-driven solutions for healthcare require both infrastructure investment and coordination between clinical institutions. “We envision that in such a data-enabled environment, the translation and application of biomedical research towards patients and their unmet needs will become a seamless routine process,” says Dr Jasmin Schulz, chief coordinator of Clinnova at the Luxembourg Institute of Health. The project’s stakeholders also believe that translational research initiatives focused on patients will evolve to become a major driver for fundamental research, thereby increasing the amount of therapeutic possibilities for patients in the future.

Clinnova will significantly contribute to Luxembourg’s research environment and the expansion of its positive image throughout the world.

“By leveraging data federation, standardisation and interoperability, Clinnova is poised to foster AI-driven precision medicine at an unprecedented scale,” comments Claude Meisch, Minister of Higher Education and Research. “By utilising international and interdisciplinary expertise anchored within the national priority of personalised healthcare, the project fully aligns with the Luxembourg National Research and Innovation Strategy. Clinnova will significantly contribute to Luxembourg’s research environment and the expansion of its positive image throughout the world.”

Photo credits: Luxembourg Institute of Health

Read more

ESRIC Start-up Support Programme welcomes the five new ventures


Launched in 2021, the Luxembourg-based Start-up Support Programme is the first worldwide incubation programme, entirely dedicated to the field of space resources utilisation.
Read more

“Luxembourg exceeds my expectations”


Korean start-up Posture AI addresses a common health problem: backpain. After developing its artificial intelligence solution using smart posture devices from its base in South Korea, the company has now chosen Luxembourg as its base for targeting the European market and moving forward with the data dimension of its products and services.
Read more

New law introduced in Luxembourg to facilitate the hiring of skilled labour


The new law simplifies the hiring of non-EU nationals and grants family members of third-country nationals holding a residence permit access to the labour market as soon as they arrive in Luxembourg.
Read more

"Supporting the development of the start-up ecosystem in Luxembourg"


Minister of the Economy, Franz Fayot, discusses the recent startup roadmap “From Seed to Scale” designed to support the ecosystem's continuous expansion as it navigates a new phase of maturity.
Read more

Inflation in Luxembourg continues to rank among the EU’s lowest


Luxembourg recorded the second lowest annual inflation rate in the EU, according to the latest July figures shared by the statistical office of the European Union, Eurostat.
Read more

All news